Query psy11469
Match_columns 267
No_of_seqs 229 out of 1639
Neff 7.7
Searched_HMMs 46136
Date Fri Aug 16 19:14:50 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy11469.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/11469hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PF01582 TIR: TIR domain; Int 99.9 9.1E-25 2E-29 176.7 6.9 115 138-256 1-116 (141)
2 smart00255 TIR Toll - interleu 99.8 7.2E-21 1.6E-25 152.7 9.2 113 136-257 2-117 (140)
3 PLN03194 putative disease resi 99.8 3E-18 6.5E-23 142.8 9.5 98 132-239 23-122 (187)
4 PF13676 TIR_2: TIR domain; PD 99.7 3.3E-18 7.2E-23 130.4 -3.2 89 138-236 1-89 (102)
5 KOG4237|consensus 99.6 1.1E-16 2.4E-21 145.9 4.3 108 1-136 348-456 (498)
6 PLN03210 Resistant to P. syrin 99.1 2E-10 4.3E-15 121.0 8.2 97 135-238 12-110 (1153)
7 smart00082 LRRCT Leucine rich 99.0 1.1E-10 2.4E-15 77.6 2.2 50 9-68 1-51 (51)
8 TIGR00864 PCC polycystin catio 98.8 5.2E-09 1.1E-13 114.1 4.4 62 1-70 21-83 (2740)
9 KOG3678|consensus 98.7 7.1E-08 1.5E-12 90.4 8.2 99 127-234 604-710 (832)
10 PF08357 SEFIR: SEFIR domain; 98.4 1.2E-06 2.6E-11 71.1 8.0 64 138-204 3-71 (150)
11 PF08937 DUF1863: MTH538 TIR-l 98.3 5E-07 1.1E-11 72.0 4.4 98 136-239 1-113 (130)
12 KOG4237|consensus 97.9 1.2E-05 2.7E-10 74.4 3.7 72 56-136 7-79 (498)
13 KOG4194|consensus 97.8 7.2E-06 1.6E-10 79.3 1.4 60 2-70 442-501 (873)
14 smart00013 LRRNT Leucine rich 97.6 7E-05 1.5E-09 45.2 2.8 32 90-127 1-32 (33)
15 PF01462 LRRNT: Leucine rich r 97.2 0.00023 5E-09 41.3 2.2 28 90-123 1-28 (28)
16 PF10137 TIR-like: Predicted n 97.1 0.0036 7.7E-08 49.6 8.7 90 138-235 2-104 (125)
17 PF01463 LRRCT: Leucine rich r 94.1 0.026 5.7E-07 31.6 1.1 25 40-68 1-25 (25)
18 COG4271 Predicted nucleotide-b 88.5 2.5 5.5E-05 36.0 7.5 89 137-233 84-186 (233)
19 KOG4194|consensus 84.8 0.96 2.1E-05 44.8 3.6 42 89-136 44-90 (873)
20 PF05014 Nuc_deoxyrib_tr: Nucl 80.1 6.2 0.00013 30.0 5.9 84 142-235 8-99 (113)
21 PF13271 DUF4062: Domain of un 73.0 14 0.0003 26.6 5.8 62 138-203 2-64 (83)
22 PF13504 LRR_7: Leucine rich r 69.7 3 6.6E-05 20.9 1.2 12 1-12 3-14 (17)
23 COG4916 Uncharacterized protei 58.2 13 0.00028 33.1 3.7 83 133-219 175-262 (329)
24 PF00560 LRR_1: Leucine Rich R 55.2 5.4 0.00012 21.2 0.5 12 1-12 2-13 (22)
25 smart00368 LRR_RI Leucine rich 53.1 8.4 0.00018 21.8 1.2 13 1-13 4-16 (28)
26 PF04723 GRDA: Glycine reducta 44.0 1.7E+02 0.0037 23.6 8.1 85 166-265 8-95 (150)
27 PF10609 ParA: ParA/MinD ATPas 43.1 37 0.0008 24.7 3.5 45 172-217 6-50 (81)
28 cd00138 PLDc Phospholipase D. 41.2 88 0.0019 25.0 6.0 28 176-204 18-45 (176)
29 PF13516 LRR_6: Leucine Rich r 36.4 20 0.00042 19.1 0.9 12 1-12 4-15 (24)
30 PRK13793 nicotinamide-nucleoti 36.3 2.7E+02 0.0059 23.7 8.8 78 181-263 20-102 (196)
31 smart00370 LRR Leucine-rich re 35.8 23 0.0005 19.2 1.2 11 1-11 4-14 (26)
32 smart00369 LRR_TYP Leucine-ric 35.8 23 0.0005 19.2 1.2 11 1-11 4-14 (26)
33 cd00860 ThrRS_anticodon ThrRS 32.6 1E+02 0.0022 21.6 4.5 62 136-205 2-64 (91)
34 PF12799 LRR_4: Leucine Rich r 31.4 32 0.0007 21.5 1.5 12 1-12 26-37 (44)
35 PF09101 Exotox-A_bind: Exotox 29.7 5.6 0.00012 34.1 -3.0 35 140-174 101-135 (262)
36 PLN02352 phospholipase D epsil 28.6 1.7E+02 0.0036 30.3 6.7 55 180-234 453-520 (758)
37 cd00738 HGTP_anticodon HGTP an 27.6 1.7E+02 0.0036 20.5 5.0 61 136-204 2-66 (94)
38 PLN02866 phospholipase D 26.5 1.2E+02 0.0027 32.4 5.4 60 176-237 341-408 (1068)
39 cd02168 NMNAT_Nudix Nicotinami 26.1 3.8E+02 0.0083 22.2 9.0 55 181-236 15-77 (181)
40 PF00009 GTP_EFTU: Elongation 25.8 2E+02 0.0042 23.5 5.7 27 176-202 78-104 (188)
41 cd03415 CbiX_CbiC Archaeal sir 25.4 2.5E+02 0.0055 21.9 5.9 97 139-240 5-112 (125)
42 KOG2869|consensus 23.5 1.4E+02 0.0029 27.8 4.5 42 180-221 184-230 (379)
43 PRK10569 NAD(P)H-dependent FMN 22.8 4.5E+02 0.0098 21.9 9.0 98 152-258 21-129 (191)
44 PHA02820 phospholipase-D-like 21.3 3.5E+02 0.0076 25.8 7.1 41 180-220 218-265 (424)
45 PRK11263 cardiolipin synthase 21.2 1.7E+02 0.0038 27.8 5.0 46 175-222 14-59 (411)
46 cd03111 CpaE_like This protein 21.1 1.8E+02 0.0039 21.5 4.2 31 173-206 49-79 (106)
47 cd00858 GlyRS_anticodon GlyRS 20.8 3.7E+02 0.008 20.4 6.0 61 136-205 27-90 (121)
48 COG4916 Uncharacterized protei 20.6 1.3E+02 0.0028 27.0 3.6 97 135-235 6-105 (329)
49 PF09419 PGP_phosphatase: Mito 20.4 3.8E+02 0.0082 22.2 6.3 47 158-206 36-90 (168)
50 cd01884 EF_Tu EF-Tu subfamily. 20.3 3.8E+02 0.0082 22.3 6.5 27 176-202 73-99 (195)
No 1
>PF01582 TIR: TIR domain; InterPro: IPR000157 In Drosophila melanogaster the Toll protein is involved in establishment of dorso-ventral polarity in the embryo. In addition, members of the Toll family play a key role in innate antibacterial and antifungal immunity in insects as well as in mammals. These proteins are type-I transmembrane receptors that share an intracellular 200 residue domain with the interleukin-1 receptor (IL-1R), the Toll/IL-1R homologous region (TIR). The similarity between Toll-like receptors (LTRs) and IL-1R is not restricted to sequence homology since these proteins also share a similar signalling pathway. They both induce the activation of a Rel type transcription factor via an adaptor protein and a protein kinase []. Interestingly, MyD88, a cytoplasmic adaptor protein found in mammals, contains a TIR domain associated to a DEATH domain (see IPR000488 from INTERPRO) [, , ]. Besides the mammalian and Drosophila melanogaster proteins, a TIR domain is also found in a number of plant proteins implicated in host defence []. As MyD88, these proteins are cytoplasmic. Site directed mutagenesis and deletion analysis have shown that the TIR domain is essential for Toll and IL-1R activities. Sequence analysis have revealed the presence of three highly conserved regions among the different members of the family: box 1 (FDAFISY), box 2 (GYKLC-RD-PG), and box 3 (a conserved W surrounded by basic residues). It has been proposed that boxes 1 and 2 are involved in the binding of proteins involved in signalling, whereas box 3 is primarily involved in directing localization of receptor, perhaps through interactions with cytoskeletal elements [].; GO: 0005515 protein binding, 0007165 signal transduction, 0005622 intracellular; PDB: 3J0A_A 2J67_B 3JRN_A 1FYV_A 1O77_D 1FYX_A 1FYW_A 3OZI_B 1T3G_B 2JS7_A ....
Probab=99.91 E-value=9.1e-25 Score=176.70 Aligned_cols=115 Identities=30% Similarity=0.387 Sum_probs=99.5
Q ss_pred ceeecCC-CCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHHHHHH
Q psy11469 138 AYVIYSL-KDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPEFKSA 216 (267)
Q Consensus 138 aFIsy~~-~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e~~~a 216 (267)
|||||++ +|++|+.++|.+.||++++|+++|+++||+.||. .+.++|.++|++||++|+|+|++|++|+||.+|++.|
T Consensus 1 vfisy~~~~d~~~~~~~L~~~Le~~~~g~~~c~~~rD~~~G~-~~~~~i~~~i~~Sr~~I~VlS~~y~~s~wc~~el~~a 79 (141)
T PF01582_consen 1 VFISYSGKDDREWFVSHLLPELEERPYGYKLCLDERDFLPGE-SILDNIQEAIERSRRTIVVLSRNYLSSEWCLFELQEA 79 (141)
T ss_dssp EEEEE-GHHGHHHHHHCHHHHHHCTSSTS-EEEHHHCTSSSS-CHHHHHHHHHHTEEEEEEEESHHHHHHTHHHHHHHHH
T ss_pred cEEEeCCCCcHHHHHHHHHHHHHhCCCCeEEEEechhhcccc-cccchhhHhhhhceeeEEEeecccccccchhhhhhhh
Confidence 7999999 8999999999999999767999999999999999 9999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCcEEEEEcCCCCCccccCCccHHHHHHHhhh
Q psy11469 217 LNGSLMRHRKPLFIIMLPPHSNILVIMPMSIYHLSVLLQD 256 (267)
Q Consensus 217 ~~~~~~~~~~~lI~v~~~~i~~~~~~~p~~~~~l~~l~~~ 256 (267)
++++.++++.++|+|+++++++.. ++ ....++.+++.
T Consensus 80 ~~~~~~~~~~~~Il~v~~~v~~~~--~~-~~~~~~~~~~~ 116 (141)
T PF01582_consen 80 LERLLEEGRDKLILPVFYDVSPSD--VR-PDQSLRFLLRF 116 (141)
T ss_dssp HHHHHCSTCTTEEEEESSSS-CHH--CH-THHHHHHHHHC
T ss_pred hhhccccccccceeeEeccCChhh--cC-hhhhHHHHHHh
Confidence 999999877788888888999887 32 13445554444
No 2
>smart00255 TIR Toll - interleukin 1 - resistance.
Probab=99.84 E-value=7.2e-21 Score=152.69 Aligned_cols=113 Identities=21% Similarity=0.267 Sum_probs=88.9
Q ss_pred CCceeecCCC---CHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHH
Q psy11469 136 CQAYVIYSLK---DEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPE 212 (267)
Q Consensus 136 ~DaFIsy~~~---D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e 212 (267)
|||||||+++ +++||. +|...|+. .|+.++ .+|+.+|. ...++|.++|++|+++|+|+||+|++|.||..|
T Consensus 2 ~dvFISys~~~~~~~~~v~-~L~~~l~~--~~~~v~--~d~~~~~~-~~~~~i~~~i~~s~~~i~vlS~~~~~S~w~~~E 75 (140)
T smart00255 2 YDVFISYSGKEDVRNEFLS-HLLEKLRG--YGLCVF--IDDFEPGG-GDLEEIDEAIEKSRIAIVVLSPNYAESEWCLDE 75 (140)
T ss_pred CeEEEECCCCHHHHHHHHH-HHHHHhhc--CCcEEE--ecCccccc-chHHHHHHHHHHCcEEEEEECcccccChhHHHH
Confidence 8999999995 344554 45554444 245554 45777887 666799999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCcEEEEEcCCCCCccccCCccHHHHHHHhhhc
Q psy11469 213 FKSALNGSLMRHRKPLFIIMLPPHSNILVIMPMSIYHLSVLLQDN 257 (267)
Q Consensus 213 ~~~a~~~~~~~~~~~lI~v~~~~i~~~~~~~p~~~~~l~~l~~~~ 257 (267)
++.|+++..+++.++||||++++++... +.....|+.++..|
T Consensus 76 ~~~a~~~~~~~~~~~iIPI~~~~~~~~~---~~~~~~l~~~~~~~ 117 (140)
T smart00255 76 LVAALENALEEGGLRVIPIFYEVIPSDV---RKQPGKFRKVLKKN 117 (140)
T ss_pred HHHHHHHHHHcCCCeEEEEEEecChHHH---HhcccHHHHHHHHH
Confidence 9999999887778899999999997432 23456677777766
No 3
>PLN03194 putative disease resistance protein; Provisional
Probab=99.76 E-value=3e-18 Score=142.78 Aligned_cols=98 Identities=13% Similarity=0.221 Sum_probs=88.7
Q ss_pred cCCCCCceeecCCCCH--HHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccccCc
Q psy11469 132 DDTPCQAYVIYSLKDE--PFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWS 209 (267)
Q Consensus 132 ~~n~~DaFIsy~~~D~--~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~ 209 (267)
..+.|||||||.++|. .||. +|...|++ .|+++|+++.++.+|+ .+.+.|..||++|+..|+|+|++|..|.||
T Consensus 23 ~~~~yDVFISFrG~DtR~~Fvs-hL~~aL~~--~GI~vF~D~~el~~G~-~i~~~L~~AIeeSri~IvVfS~~Ya~S~WC 98 (187)
T PLN03194 23 SAKPCDVFINHRGIDTKRTIAT-LLYDHLSR--LNLRPFLDNKNMKPGD-KLFDKINSAIRNCKVGVAVFSPRYCESYFC 98 (187)
T ss_pred CCCCCcEEEeCCCccccccHHH-HHHHHHHH--CCCEEEEcCccccCCC-cHHHHHHHHHHhCeEEEEEECCCcccchhH
Confidence 4567999999999995 7997 89999999 5999999999999999 999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhhcCCCcEEEEEcCCCCCc
Q psy11469 210 RPEFKSALNGSLMRHRKPLFIIMLPPHSNI 239 (267)
Q Consensus 210 ~~e~~~a~~~~~~~~~~~lI~v~~~~i~~~ 239 (267)
..|+..++.. +++|||||++ +++.
T Consensus 99 LdEL~~I~e~-----~~~ViPIFY~-VdPs 122 (187)
T PLN03194 99 LHELALIMES-----KKRVIPIFCD-VKPS 122 (187)
T ss_pred HHHHHHHHHc-----CCEEEEEEec-CCHH
Confidence 9999999863 4579999997 4443
No 4
>PF13676 TIR_2: TIR domain; PDB: 3H16_B 3UB4_A 2Y92_A 3UB3_A 3UB2_A.
Probab=99.65 E-value=3.3e-18 Score=130.39 Aligned_cols=89 Identities=27% Similarity=0.486 Sum_probs=77.2
Q ss_pred ceeecCCCCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHHHHHHH
Q psy11469 138 AYVIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPEFKSAL 217 (267)
Q Consensus 138 aFIsy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e~~~a~ 217 (267)
+||||+++|++||. +|...|++ .|+++|++. |+.+|. .+.+.|.++|++|+.+|+++|++|++|+||+.|+..|.
T Consensus 1 VFIS~~~~D~~~a~-~l~~~L~~--~g~~v~~d~-~~~~g~-~~~~~i~~~i~~s~~~i~~~S~~~~~s~~~~~E~~~a~ 75 (102)
T PF13676_consen 1 VFISYSSEDREFAE-RLAERLES--AGIRVFLDR-DIPPGE-DWREEIERAIERSDCVIVLLSPNYLKSPWCRFELGAAW 75 (102)
T ss_dssp EEEEEEGGGCCCHH-HHHHHHHH--TT--EE-GG-EE-TTS--HHCCCHHCCTTEEEEEEEEEHHHHCTHHHHHHHHHHH
T ss_pred eEEEecCCcHHHHH-HHHHHHhh--cCCEEEEEE-eCCCCC-CHHHHHHHHHHhCCEEEEEECcccccChHHHHHHHHHH
Confidence 69999999999997 79999998 499999996 999999 99999999999999999999999999999999999994
Q ss_pred HHHhhcCCCcEEEEEcCCC
Q psy11469 218 NGSLMRHRKPLFIIMLPPH 236 (267)
Q Consensus 218 ~~~~~~~~~~lI~v~~~~i 236 (267)
. .+++||||++++.
T Consensus 76 ~-----~~~~iipv~~~~~ 89 (102)
T PF13676_consen 76 K-----RGKPIIPVRLDPC 89 (102)
T ss_dssp C-----TSESEEEEECSGG
T ss_pred H-----CCCEEEEEEECCc
Confidence 3 4458999998875
No 5
>KOG4237|consensus
Probab=99.64 E-value=1.1e-16 Score=145.93 Aligned_cols=108 Identities=28% Similarity=0.545 Sum_probs=91.9
Q ss_pred CCeEEecCCCcccccCchHHHHHHhhccCCCCcccccCCCceecCCcc-cccccccccccccCCceeccCCCcceecccc
Q psy11469 1 MPKFFLGENPFECDCKMEWLQRAHEIHKDGIYPEIADLESLYCRMVYE-ENLITYDNIFIADSSKFLCDYEEHCFSLCRC 79 (267)
Q Consensus 1 ~~~l~L~~NP~~CdC~l~wl~~w~~~~~~~~~~~~~~~~~~~C~~P~~-~g~l~~~~l~~~~~~~~~C~~~~~~~~~~~~ 79 (267)
|++|+|-+|||.|||+++||.+|++. +. ..++..|++|.. ++. ++.++...++.|...+..
T Consensus 348 l~~l~l~~Np~~CnC~l~wl~~Wlr~----~~----~~~~~~Cq~p~~~~~~----~~~dv~~~~~~c~~~ee~------ 409 (498)
T KOG4237|consen 348 LSTLNLLSNPFNCNCRLAWLGEWLRK----KS----VVGNPRCQSPGFVRQI----PISDVAFGDFRCGGPEEL------ 409 (498)
T ss_pred eeeeehccCcccCccchHHHHHHHhh----CC----CCCCCCCCCCchhccc----cchhccccccccCCcccc------
Confidence 57899999999999999999999973 11 138899999999 666 999999999999955432
Q ss_pred ccCCccccCCCCCccceeeecCCCceeEEEcCcccccccCCCCCCCcceecccCCCC
Q psy11469 80 CEYGACDCRMSCPFNCTCYNDQAWTTNIVDCSNSQYNHVPLFVPMDATTIYLDDTPC 136 (267)
Q Consensus 80 ~~~~~~~~~~~cp~~c~c~~~~~w~~~~v~C~~~gl~~ip~~~p~~~~~L~L~~n~~ 136 (267)
.|.....||..|+|. ...|.|++++++.+|++||.+++++|++||.+
T Consensus 410 ----~~~~s~~cP~~c~c~------~tVvRcSnk~lk~lp~~iP~d~telyl~gn~~ 456 (498)
T KOG4237|consen 410 ----GCLTSSPCPPPCTCL------DTVVRCSNKLLKLLPRGIPVDVTELYLDGNAI 456 (498)
T ss_pred ----CCCCCCCCCCCcchh------hhhHhhcccchhhcCCCCCchhHHHhcccchh
Confidence 233356799999998 57899999999999999999999999999986
No 6
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.09 E-value=2e-10 Score=121.02 Aligned_cols=97 Identities=12% Similarity=0.174 Sum_probs=86.6
Q ss_pred CCCceeecCCCC--HHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHH
Q psy11469 135 PCQAYVIYSLKD--EPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPE 212 (267)
Q Consensus 135 ~~DaFIsy~~~D--~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e 212 (267)
.||||+||.++| ..|+. +|...|.+ .|+.++.++ ++..|+ .+..++.+||++||-.|+|+|++|..|.||..|
T Consensus 12 ~~~vf~sfrg~d~r~~f~~-hl~~~l~~--~~i~~f~d~-~~~~g~-~~~~~l~~~i~~s~~~ivv~s~~ya~s~wcl~e 86 (1153)
T PLN03210 12 VYDVFPSFSGEDVRITFLS-HFLKELDR--KLIIAFKDN-EIERSQ-SLDPELKQAIRDSRIAVVVFSKNYASSSWCLNE 86 (1153)
T ss_pred CCcEEeeCCCcccccCHHH-HHHHHHHH--CCCeEEccC-CccCCC-cccHHHHHHHHhCeEEEEEecCCcccchHHHHH
Confidence 599999999998 57997 89999998 599999865 799999 999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCcEEEEEcCCCCC
Q psy11469 213 FKSALNGSLMRHRKPLFIIMLPPHSN 238 (267)
Q Consensus 213 ~~~a~~~~~~~~~~~lI~v~~~~i~~ 238 (267)
+...+... ++.+..||||||+ +.+
T Consensus 87 l~~i~~~~-~~~~~~v~pvfy~-v~p 110 (1153)
T PLN03210 87 LLEIVRCK-EELGQLVIPVFYG-LDP 110 (1153)
T ss_pred HHHHHHhh-hhcCceEEEEEec-ccH
Confidence 99998765 4566789999997 443
No 7
>smart00082 LRRCT Leucine rich repeat C-terminal domain.
Probab=99.03 E-value=1.1e-10 Score=77.62 Aligned_cols=50 Identities=32% Similarity=0.583 Sum_probs=40.4
Q ss_pred CCcccccCchHHHHHHhhccCCCCcccccCCCceecCCcc-cccccccccccccCCceecc
Q psy11469 9 NPFECDCKMEWLQRAHEIHKDGIYPEIADLESLYCRMVYE-ENLITYDNIFIADSSKFLCD 68 (267)
Q Consensus 9 NP~~CdC~l~wl~~w~~~~~~~~~~~~~~~~~~~C~~P~~-~g~l~~~~l~~~~~~~~~C~ 68 (267)
|||.|||++.||++|+.. +..+.+.+.++|.+|.. + . ++.++..+++.|.
T Consensus 1 NP~~CdC~l~~~~~w~~~-----~~~~~~~~~~~C~~P~~~~-~----~l~~~~~~~~~C~ 51 (51)
T smart00082 1 NPFICDCELRWLLRWLQA-----NEHLQDPVSLRCASPSSLR-G----PLLELLHSEFKCP 51 (51)
T ss_pred CCccCcCCchHHHHHHHh-----CCccCCCCCCEeCCcHHHH-h----HHHcCCHhhCCCc
Confidence 999999999999999962 22244567999999999 5 3 7888888778774
No 8
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=98.76 E-value=5.2e-09 Score=114.09 Aligned_cols=62 Identities=26% Similarity=0.333 Sum_probs=51.9
Q ss_pred CCeEEecCCCcccccCchHHHHHHhhccCCCCcccccCCCceecCCcc-cccccccccccccCCceeccCC
Q psy11469 1 MPKFFLGENPFECDCKMEWLQRAHEIHKDGIYPEIADLESLYCRMVYE-ENLITYDNIFIADSSKFLCDYE 70 (267)
Q Consensus 1 ~~~l~L~~NP~~CdC~l~wl~~w~~~~~~~~~~~~~~~~~~~C~~P~~-~g~l~~~~l~~~~~~~~~C~~~ 70 (267)
|++|+|++|||+|||+|+||++|++. ...++.....++|.+|.. +|+ +|.+++..++.|...
T Consensus 21 L~~LdLsgNPw~CDC~L~WL~~WL~~----~~v~v~~~~~i~CasP~~LrG~----~L~~l~~~d~~C~~~ 83 (2740)
T TIGR00864 21 LSEIDLSGNPFECDCGLARLPRWAEE----KGVKVRQPEAALCAGPGALAGQ----PLLGIPLLDSGCDEE 83 (2740)
T ss_pred ceEEEeeCCccccccccHHHHHHHHh----cCccccCCcccCCCCChHHCCC----CcccCCcccCCCCCc
Confidence 67999999999999999999999973 233344567899999999 777 999999888888743
No 9
>KOG3678|consensus
Probab=98.66 E-value=7.1e-08 Score=90.36 Aligned_cols=99 Identities=14% Similarity=0.233 Sum_probs=78.6
Q ss_pred ceecccCCCCCceeecCCCCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCccc-
Q psy11469 127 TTIYLDDTPCQAYVIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIY- 205 (267)
Q Consensus 127 ~~L~L~~n~~DaFIsy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~- 205 (267)
++....+..+|+||||...--.=...-+...|+- .||+|+++..-+..|. +-+.+...|..++.+|+||||+.|.
T Consensus 604 v~~a~~skq~DVFISYRRstGnQLASLiKV~LQL--~GyrVFIDVdKL~AGK--FdssLlkni~aAkhFiLVLtP~sLDr 679 (832)
T KOG3678|consen 604 VEVAMLSKQIDVFISYRRSTGNQLASLIKVLLQL--RGYRVFIDVDKLYAGK--FDSSLLKNIQAAKHFILVLTPNSLDR 679 (832)
T ss_pred cccccccCCcceEEEeeccccHHHHHHHHHHHHh--cCceEEEehhhhhccc--ccHHHHHHHHhhheeEEEeCcchHHH
Confidence 4555677789999999986543233234444544 5999999999999997 6677888999999999999999994
Q ss_pred -------ccCcHHHHHHHHHHHhhcCCCcEEEEEcC
Q psy11469 206 -------GDWSRPEFKSALNGSLMRHRKPLFIIMLP 234 (267)
Q Consensus 206 -------s~w~~~e~~~a~~~~~~~~~~~lI~v~~~ 234 (267)
..|...|+..|++. .+.|||||-.
T Consensus 680 ~lnD~nCeDWVHKEl~~Afe~-----~KNIiPI~D~ 710 (832)
T KOG3678|consen 680 LLNDDNCEDWVHKELKCAFEH-----QKNIIPIFDT 710 (832)
T ss_pred HhccccHHHHHHHHHHHHHHh-----cCCeeeeecc
Confidence 36999999999874 5789999966
No 10
>PF08357 SEFIR: SEFIR domain; InterPro: IPR013568 This domain is found in IL17 receptors (IL17Rs, e.g. Q60943 from SWISSPROT) and SEF proteins (e.g. Q8QHJ9 from SWISSPROT). The latter are feedback inhibitors of FGF signalling and are also thought to be receptors. Due to its similarity to the TIR domain (IPR000157 from INTERPRO), the SEFIR region is thought to be involved in homotypic interactions with other SEFIR/TIR-domain-containing proteins. Thus, SEFs and IL17Rs may be involved in TOLL/IL1R-like signalling pathways [].
Probab=98.40 E-value=1.2e-06 Score=71.14 Aligned_cols=64 Identities=20% Similarity=0.348 Sum_probs=55.8
Q ss_pred ceeecCCCCH---HHHHHhhhhccCCCCCceEEEEecCCCC--CCcccHHHHHHHHHHhcCEEEEEecCCcc
Q psy11469 138 AYVIYSLKDE---PFVKQILLPGLAFKDPAVKLRVHHRDLN--PNLISTADFVTNSIERSEKVIMVLSRAFI 204 (267)
Q Consensus 138 aFIsy~~~D~---~~v~~~L~~~Le~~~~g~~v~~~~rD~~--~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl 204 (267)
||||||++++ +||. .|+..|++. .|+.+.++.+|.. ++. .....+.+.+++++++|+|.||.+.
T Consensus 3 VfI~Ys~d~~~h~~~V~-~la~~L~~~-~g~~V~lD~~~~~~i~~~-g~~~W~~~~~~~ad~Vliv~S~~~~ 71 (150)
T PF08357_consen 3 VFISYSHDSEEHKEWVL-ALAEFLRQN-CGIDVILDQWELNEIARQ-GPPRWMERQIREADKVLIVCSPGYK 71 (150)
T ss_pred EEEEeCCCCHHHHHHHH-HHHHHHHhc-cCCceeecHHhhcccccC-CHHHHHHHHHhcCCEEEEEeccchh
Confidence 7999999664 5798 699999885 5999999999994 477 8999999999999999999996654
No 11
>PF08937 DUF1863: MTH538 TIR-like domain (DUF1863); InterPro: IPR015032 This protein adopts the flavodoxin fold, that is, five parallel beta-strands and four helical segments. The structure is a three-layer sandwich with alpha-1 and alpha-4 on one side of the beta-sheet, and alpha-2 and alpha-3 on the other side. Probable role in signal transduction as a phosphorylation-independent conformational switch protein []. This domain is similar to the TIR domain [].; PDB: 3HYN_A.
Probab=98.34 E-value=5e-07 Score=71.96 Aligned_cols=98 Identities=18% Similarity=0.245 Sum_probs=51.7
Q ss_pred CCceeecCCCCHHHHHHhhhhccCCC-----CCceEE----------EEecCCCCCCcccHHHHHHHHHHhcCEEEEEec
Q psy11469 136 CQAYVIYSLKDEPFVKQILLPGLAFK-----DPAVKL----------RVHHRDLNPNLISTADFVTNSIERSEKVIMVLS 200 (267)
Q Consensus 136 ~DaFIsy~~~D~~~v~~~L~~~Le~~-----~~g~~v----------~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS 200 (267)
+.+||||+++|..+..+.|...+.+. ...+.. .-...|..... .+-..|.+.|..|..+||++|
T Consensus 1 ~~vFIS~~~~d~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ik~~I~~~i~~s~~~IVLig 79 (130)
T PF08937_consen 1 YKVFISYSHDDDDWYYDQLKEWLENSYEIPRDKNFDFRFYDVSKWEPIRSRDDDSSSE-YIKRKIRERIKNSSVTIVLIG 79 (130)
T ss_dssp ----------THH-HHHHHHHHHHH-------TTSS--BT---TTT---TTS---TTT-THHHHHHHHHHTEEEEEEE--
T ss_pred CCccccccccCcHHHHHHHHHHhccccccccccccccCcccccccCcccCccccchHH-HHHHHHHHHHhcCCEEEEEeC
Confidence 37999999999984334677666552 011211 01122222344 788999999999999999999
Q ss_pred CCcccccCcHHHHHHHHHHHhhcCCCcEEEEEcCCCCCc
Q psy11469 201 RAFIYGDWSRPEFKSALNGSLMRHRKPLFIIMLPPHSNI 239 (267)
Q Consensus 201 ~~fl~s~w~~~e~~~a~~~~~~~~~~~lI~v~~~~i~~~ 239 (267)
++--.|.|...|++.|+. ..++||.|.+......
T Consensus 80 ~~T~~s~wV~~EI~~A~~-----~~~~Ii~V~~~~~~~~ 113 (130)
T PF08937_consen 80 PNTAKSKWVNWEIEYALK-----KGKPIIGVYLPGLKDR 113 (130)
T ss_dssp TT----HHHHHHHHHHTT-----T---EEEEETT--SGG
T ss_pred CCcccCcHHHHHHHHHHH-----CCCCEEEEECCCCCCC
Confidence 999999999999999976 5678999998876544
No 12
>KOG4237|consensus
Probab=97.85 E-value=1.2e-05 Score=74.40 Aligned_cols=72 Identities=28% Similarity=0.584 Sum_probs=54.5
Q ss_pred ccccccCCceeccCCCcceeccccccCCcccc-CCCCCccceeeecCCCceeEEEcCcccccccCCCCCCCcceecccCC
Q psy11469 56 NIFIADSSKFLCDYEEHCFSLCRCCEYGACDC-RMSCPFNCTCYNDQAWTTNIVDCSNSQYNHVPLFVPMDATTIYLDDT 134 (267)
Q Consensus 56 ~l~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~-~~~cp~~c~c~~~~~w~~~~v~C~~~gl~~ip~~~p~~~~~L~L~~n 134 (267)
.+..+..+.+.|......... ..|.- ...||..|+|-... ...|+|+.+||++||..+|.++++++||.|
T Consensus 7 ~v~~l~~s~~~csg~~s~~~~------~~C~~~~~~CP~pC~Cs~~~---g~~VdCr~~GL~eVP~~LP~~tveirLdqN 77 (498)
T KOG4237|consen 7 NVADLQKSEFVCSGLQSAWAV------PTCAHSASACPAPCTCSDVE---GGIVDCRGKGLTEVPANLPPETVEIRLDQN 77 (498)
T ss_pred cccccccceeeecCchhhhhh------hhhhhccccCCCCcccCCCC---CceEEccCCCcccCcccCCCcceEEEeccC
Confidence 677777777888876543111 11111 34799999998433 479999999999999999999999999999
Q ss_pred CC
Q psy11469 135 PC 136 (267)
Q Consensus 135 ~~ 136 (267)
.+
T Consensus 78 ~I 79 (498)
T KOG4237|consen 78 QI 79 (498)
T ss_pred Cc
Confidence 65
No 13
>KOG4194|consensus
Probab=97.80 E-value=7.2e-06 Score=79.27 Aligned_cols=60 Identities=18% Similarity=0.423 Sum_probs=46.2
Q ss_pred CeEEecCCCcccccCchHHHHHHhhccCCCCcccccCCCceecCCcccccccccccccccCCceeccCC
Q psy11469 2 PKFFLGENPFECDCKMEWLQRAHEIHKDGIYPEIADLESLYCRMVYEENLITYDNIFIADSSKFLCDYE 70 (267)
Q Consensus 2 ~~l~L~~NP~~CdC~l~wl~~w~~~~~~~~~~~~~~~~~~~C~~P~~~g~l~~~~l~~~~~~~~~C~~~ 70 (267)
++|-+..-.|.|||+++||.+|+.. ..++ ..-.++|+.|++ |++..+.++++.++.|...
T Consensus 442 k~Lv~nSssflCDCql~Wl~qWl~~----~~lq--~sv~a~CayPe~---Lad~~i~svd~~~lvC~Ds 501 (873)
T KOG4194|consen 442 KELVMNSSSFLCDCQLKWLAQWLYR----RKLQ--SSVIAKCAYPEP---LADQSIVSVDTANLVCDDS 501 (873)
T ss_pred hhhhhcccceEEeccHHHHHHHHHh----cccc--cceeeeccCCcc---cccceeEeechhhceecCC
Confidence 4445555568899999999999973 2222 346789999999 5555999999999999843
No 14
>smart00013 LRRNT Leucine rich repeat N-terminal domain.
Probab=97.57 E-value=7e-05 Score=45.21 Aligned_cols=32 Identities=44% Similarity=0.879 Sum_probs=28.3
Q ss_pred CCCccceeeecCCCceeEEEcCcccccccCCCCCCCcc
Q psy11469 90 SCPFNCTCYNDQAWTTNIVDCSNSQYNHVPLFVPMDAT 127 (267)
Q Consensus 90 ~cp~~c~c~~~~~w~~~~v~C~~~gl~~ip~~~p~~~~ 127 (267)
.||..|+|+ ...|+|++++|+++|.+||.+++
T Consensus 1 ~CP~~C~C~------~~~V~C~~~~L~~vP~~iP~~t~ 32 (33)
T smart00013 1 ACPAPCNCS------GTAVDCSGRGLTEVPLDLPPDTT 32 (33)
T ss_pred CcCCCCEEC------CCEeEeCCCCcCccCCCCCcccc
Confidence 389999998 46899999999999999998864
No 15
>PF01462 LRRNT: Leucine rich repeat N-terminal domain; InterPro: IPR000372 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain and a C-terminal LRR domain (IPR000483 from INTERPRO). This entry represents the N-terminal LRR domain. ; PDB: 3E6J_A 1W8A_A 2V9S_C 2V9T_B 3TWI_D 3ZYN_A 3ZYO_A 1OOK_G 1QYY_G 1SQ0_B ....
Probab=97.24 E-value=0.00023 Score=41.31 Aligned_cols=28 Identities=43% Similarity=0.827 Sum_probs=22.2
Q ss_pred CCCccceeeecCCCceeEEEcCcccccccCCCCC
Q psy11469 90 SCPFNCTCYNDQAWTTNIVDCSNSQYNHVPLFVP 123 (267)
Q Consensus 90 ~cp~~c~c~~~~~w~~~~v~C~~~gl~~ip~~~p 123 (267)
.||..|+|. ...|+|+++||+++|..+|
T Consensus 1 ~CP~~C~C~------~~~V~C~~~~L~~vP~~lP 28 (28)
T PF01462_consen 1 ACPRPCTCS------GLTVDCSGRGLTAVPSDLP 28 (28)
T ss_dssp SSETTSEEE------TTEEEETTSS-SSS-STS-
T ss_pred CcCCCCEec------CCEeECCCCCCCccCCCCc
Confidence 388999998 5789999999999999876
No 16
>PF10137 TIR-like: Predicted nucleotide-binding protein containing TIR-like domain; InterPro: IPR019302 This entry represents a TIR-like domain found in a family of prokaryotic predicted nucleotide-binding proteins. Their exact function has not, as yet, been defined.
Probab=97.14 E-value=0.0036 Score=49.62 Aligned_cols=90 Identities=11% Similarity=0.086 Sum_probs=68.5
Q ss_pred ceeecCCCCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccc---c-------
Q psy11469 138 AYVIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYG---D------- 207 (267)
Q Consensus 138 aFIsy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s---~------- 207 (267)
+||.|+ +|..++. .+...|+. .|+...+.......|. .+.|.+.+.++++.-.|+|+||+=+.. .
T Consensus 2 VFIvhg-~~~~~~~-~v~~~L~~--~~~ep~i~~~~~~~g~-tiie~le~~~~~~~faIvl~TpDD~~~~~~~~~~~~~~ 76 (125)
T PF10137_consen 2 VFIVHG-RDLAAAE-AVERFLEK--LGLEPIIWHEQPNLGQ-TIIEKLEEAADSVDFAIVLFTPDDIGYSRGEEEDLQPR 76 (125)
T ss_pred EEEEeC-CCHHHHH-HHHHHHHh--CCCceEEeecCCCCCC-chHHHHHHHhccCCEEEEEEcccccccccCCccccccc
Confidence 799999 8888886 68888886 4787767777779999 999999999999999999999964421 1
Q ss_pred ---CcHHHHHHHHHHHhhcCCCcEEEEEcCC
Q psy11469 208 ---WSRPEFKSALNGSLMRHRKPLFIIMLPP 235 (267)
Q Consensus 208 ---w~~~e~~~a~~~~~~~~~~~lI~v~~~~ 235 (267)
-..+|+-+++.++ ++++++.+.-++
T Consensus 77 aR~NVifE~G~f~g~L---Gr~rv~~l~~~~ 104 (125)
T PF10137_consen 77 ARQNVIFELGLFIGKL---GRERVFILVKGG 104 (125)
T ss_pred cccceeehhhHHHhhc---CcceEEEEEcCC
Confidence 1346666666543 456777777554
No 17
>PF01463 LRRCT: Leucine rich repeat C-terminal domain; InterPro: IPR000483 Leucine-rich repeats (LRR, see IPR001611 from INTERPRO) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions []. Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain (IPR000372 from INTERPRO) and a C-terminal LRR domain. This entry represents the C-terminal LRR domain. ; PDB: 3RFE_B 3REZ_D 2WFH_A 2V70_B 2V9S_C 2V9T_B 1W8A_A.
Probab=94.11 E-value=0.026 Score=31.64 Aligned_cols=25 Identities=20% Similarity=0.307 Sum_probs=17.5
Q ss_pred CceecCCcccccccccccccccCCceecc
Q psy11469 40 SLYCRMVYEENLITYDNIFIADSSKFLCD 68 (267)
Q Consensus 40 ~~~C~~P~~~g~l~~~~l~~~~~~~~~C~ 68 (267)
+++|++|.+ |.+ +|.++.+++|.|.
T Consensus 1 ~~~Ca~P~~---lrg-~l~~~~~~~f~C~ 25 (25)
T PF01463_consen 1 NARCASPPE---LRG-PLLDLPPSDFKCS 25 (25)
T ss_dssp T-BEEESGG---GTT-BGGGSSGGG----
T ss_pred CCccCCChH---HcC-cHhhCCcccCcCC
Confidence 468999999 677 8999998889884
No 18
>COG4271 Predicted nucleotide-binding protein containing TIR -like domain [Transcription]
Probab=88.45 E-value=2.5 Score=36.02 Aligned_cols=89 Identities=11% Similarity=0.078 Sum_probs=61.3
Q ss_pred CceeecCCCCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcc-----ccc---C
Q psy11469 137 QAYVIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFI-----YGD---W 208 (267)
Q Consensus 137 DaFIsy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl-----~s~---w 208 (267)
-|||.|+++- -+. .....|+.+ +..-..+.+-=+..|. .+.|.+...|++++.-|++++|+=. .|+ |
T Consensus 84 kvFvv~ghd~--iAr-ael~allrd-~~l~~vi~d~~~~~g~-~ile~lek~i~~v~FAi~latPDDkgy~~~~~~~k~~ 158 (233)
T COG4271 84 KVFVVSGHDA--IAR-AELEALLRD-WKLEPVILDGLFSEGQ-TILESLEKYIAEVKFAIVLATPDDKGYRAVHSREKAF 158 (233)
T ss_pred eEEEEeccHH--HHH-HHHHHHhhc-cccceEEecCcccccH-HHHHHHHHHhhhceEEEEEecCcccccccccchhhcc
Confidence 8999988765 233 455566654 3444445555567788 9999999999999999999999754 221 3
Q ss_pred ------cHHHHHHHHHHHhhcCCCcEEEEEc
Q psy11469 209 ------SRPEFKSALNGSLMRHRKPLFIIML 233 (267)
Q Consensus 209 ------~~~e~~~a~~~~~~~~~~~lI~v~~ 233 (267)
..+|+-+.+-++ ++++++++.-
T Consensus 159 praRqNVifELGm~mgrL---gRkrv~Il~k 186 (233)
T COG4271 159 PRARQNVIFELGMFMGRL---GRKRVMILMK 186 (233)
T ss_pred ccccccchhhHhhHHhhc---ccceEEEEec
Confidence 346666666554 5567766654
No 19
>KOG4194|consensus
Probab=84.81 E-value=0.96 Score=44.82 Aligned_cols=42 Identities=29% Similarity=0.711 Sum_probs=37.1
Q ss_pred CCCCccceeeecCCCceeEEEcCccccccc-----CCCCCCCcceecccCCCC
Q psy11469 89 MSCPFNCTCYNDQAWTTNIVDCSNSQYNHV-----PLFVPMDATTIYLDDTPC 136 (267)
Q Consensus 89 ~~cp~~c~c~~~~~w~~~~v~C~~~gl~~i-----p~~~p~~~~~L~L~~n~~ 136 (267)
..||..|.|. ...++|+++++..+ +..+|..+..|++++|..
T Consensus 44 ~~cpa~c~c~------~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl 90 (873)
T KOG4194|consen 44 SECPATCPCN------TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKL 90 (873)
T ss_pred ccCCCcCCCC------ceeeecCccccccccccccCCcCccceeeeecccccc
Confidence 4699999998 68899999999987 788999999999999975
No 20
>PF05014 Nuc_deoxyrib_tr: Nucleoside 2-deoxyribosyltransferase; InterPro: IPR007710 Nucleoside 2-deoxyribosyltransferase (2.4.2.6 from EC) catalyses the cleavage of the glycosidic bonds of 2-deoxyribonucleosides. Nucleoside 2-deoxyribosyltransferases can be divided into two groups based on their substrate specificity: class I enzymes are specific for the transfer of deoxyribose between two purines, while class II enzymes will transfer the deoxyribose between either purines or pyrimidines. The structure of the class I [] and class II [] enzymes are very similar. In class I enzymes, the purine base shields the active site from solvent, which the smaller pyrimidine base cannot do, while in class II enzymes the active site is shielded by a loop (residues 48-62). Both classes of enzymes are found in various Lactobacillus species and participate in nucleoside recycling in these microorganisms. This entry represents both classes of enzymes.; GO: 0050144 nucleoside deoxyribosyltransferase activity, 0070694 deoxyribonucleoside 5'-monophosphate N-glycosidase activity, 0009159 deoxyribonucleoside monophosphate catabolic process; PDB: 1S2L_A 1S2D_C 1S2I_A 1S3F_B 1S2G_C 2A0K_A 2F67_A 2F64_B 2F62_A 2F2T_A ....
Probab=80.08 E-value=6.2 Score=30.04 Aligned_cols=84 Identities=17% Similarity=0.067 Sum_probs=56.0
Q ss_pred cCCCCHHHHHHhhhhccCCCCCceEEEEecC-CCC-------CCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHHH
Q psy11469 142 YSLKDEPFVKQILLPGLAFKDPAVKLRVHHR-DLN-------PNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPEF 213 (267)
Q Consensus 142 y~~~D~~~v~~~L~~~Le~~~~g~~v~~~~r-D~~-------~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e~ 213 (267)
|+.....|+. ++...|++ .|+.++.... +.. ... .+.+.=.++|++|+-+|+++...- .+.=..+|+
T Consensus 8 F~~~~~~~~~-~~~~~L~~--~g~~v~~P~~~~~~~~~~~~~~~~-~i~~~d~~~i~~~D~via~l~~~~-~d~Gt~~El 82 (113)
T PF05014_consen 8 FSEEQKARVE-RLREALEK--NGFEVYSPQDNDENDEEDSQEWAR-EIFERDLEGIRECDIVIANLDGFR-PDSGTAFEL 82 (113)
T ss_dssp SSHHHHHHHH-HHHHHHHT--TTTEEEGGCTCSSS--TTSHHCHH-HHHHHHHHHHHHSSEEEEEECSSS---HHHHHHH
T ss_pred CCHHHHHHHH-HHHHHHHh--CCCEEEeccccccccccccchHHH-HHHHHHHHHHHHCCEEEEECCCCC-CCCcHHHHH
Confidence 3455667776 79999999 4888876652 221 112 556666779999999999999855 344467788
Q ss_pred HHHHHHHhhcCCCcEEEEEcCC
Q psy11469 214 KSALNGSLMRHRKPLFIIMLPP 235 (267)
Q Consensus 214 ~~a~~~~~~~~~~~lI~v~~~~ 235 (267)
-.|.. .+++||.+..+.
T Consensus 83 G~A~a-----lgkpv~~~~~d~ 99 (113)
T PF05014_consen 83 GYAYA-----LGKPVILLTEDD 99 (113)
T ss_dssp HHHHH-----TTSEEEEEECCC
T ss_pred HHHHH-----CCCEEEEEEcCC
Confidence 88765 345666655543
No 21
>PF13271 DUF4062: Domain of unknown function (DUF4062)
Probab=72.99 E-value=14 Score=26.64 Aligned_cols=62 Identities=8% Similarity=0.218 Sum_probs=41.3
Q ss_pred ceeecCCCCHHHHHHhhhhccCCCCCceEE-EEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCc
Q psy11469 138 AYVIYSLKDEPFVKQILLPGLAFKDPAVKL-RVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAF 203 (267)
Q Consensus 138 aFIsy~~~D~~~v~~~L~~~Le~~~~g~~v-~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~f 203 (267)
+|||-.-.|-+=..+.|...+.+ .|+.. -.+... ..+. ...+...+.|++|+..|.+|-..|
T Consensus 2 VFiSSt~~Dl~~eR~~l~~~i~~--~~~~~~~~e~~~-a~~~-~~~~~cl~~v~~cDifI~ilG~rY 64 (83)
T PF13271_consen 2 VFISSTFRDLKEERDALIEAIRR--LGCEPVGMEFFP-ASDQ-SPLEICLKEVDECDIFILILGNRY 64 (83)
T ss_pred EEEecChhhHHHHHHHHHHHHHH--CCCeeeeeeeec-CCCC-CHHHHHHHHHhhCCEEEEeecccc
Confidence 79998878854444455555544 24422 222222 2255 788999999999999999998876
No 22
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=69.68 E-value=3 Score=20.87 Aligned_cols=12 Identities=17% Similarity=0.268 Sum_probs=8.0
Q ss_pred CCeEEecCCCcc
Q psy11469 1 MPKFFLGENPFE 12 (267)
Q Consensus 1 ~~~l~L~~NP~~ 12 (267)
|++|+|++|.+.
T Consensus 3 L~~L~l~~n~L~ 14 (17)
T PF13504_consen 3 LRTLDLSNNRLT 14 (17)
T ss_dssp -SEEEETSS--S
T ss_pred cCEEECCCCCCC
Confidence 689999999864
No 23
>COG4916 Uncharacterized protein containing a TIR (Toll-Interleukin 1-resistance) domain [Function unknown]
Probab=58.23 E-value=13 Score=33.10 Aligned_cols=83 Identities=12% Similarity=0.054 Sum_probs=53.3
Q ss_pred CCCCCceeecCCCCHHHHHHhhhhccCCCCCceEEEEecCC----CCCCcccHHHHHHHHHH-hcCEEEEEecCCccccc
Q psy11469 133 DTPCQAYVIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRD----LNPNLISTADFVTNSIE-RSEKVIMVLSRAFIYGD 207 (267)
Q Consensus 133 ~n~~DaFIsy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD----~~~G~~~~~~~i~~~i~-~Sr~~I~VlS~~fl~s~ 207 (267)
...||+=+||..+-+.-|++ ....++.. .+=...+.+-| +.|| +..+-+...-. +|+-+++.+..+|....
T Consensus 175 ~~~~DiG~SFaGEAR~LVEq-V~~E~~~~-~~p~~~FYD~~~~~~L~~~--sL~~~L~~~Y~~rC~~~~VF~~~~Y~~K~ 250 (329)
T COG4916 175 EKPVDSGISFAGEARNLVEQ-VQTEHSGL-DIPTRRFYDLLVAHPLYPG--SLVSTLDPGYDIRCVVTTVFNTGSYICKS 250 (329)
T ss_pred ccccceeeEeehhhhhHHHH-HHHhhhcc-cCCceeeeechhhccccCc--cHHHhcccccCceEEEEEEEeCCceEEee
Confidence 33579999999999888863 45556543 12223333333 2344 34444443333 56667777889999999
Q ss_pred CcHHHHHHHHHH
Q psy11469 208 WSRPEFKSALNG 219 (267)
Q Consensus 208 w~~~e~~~a~~~ 219 (267)
||..|....-..
T Consensus 251 ~c~~E~~~~r~~ 262 (329)
T COG4916 251 TCHIEGLEGRLN 262 (329)
T ss_pred eeccchhhcccc
Confidence 999999987543
No 24
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=55.17 E-value=5.4 Score=21.17 Aligned_cols=12 Identities=17% Similarity=0.171 Sum_probs=10.0
Q ss_pred CCeEEecCCCcc
Q psy11469 1 MPKFFLGENPFE 12 (267)
Q Consensus 1 ~~~l~L~~NP~~ 12 (267)
|++|+|++|.+.
T Consensus 2 L~~Ldls~n~l~ 13 (22)
T PF00560_consen 2 LEYLDLSGNNLT 13 (22)
T ss_dssp ESEEEETSSEES
T ss_pred ccEEECCCCcCE
Confidence 678999999875
No 25
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=53.09 E-value=8.4 Score=21.79 Aligned_cols=13 Identities=15% Similarity=0.184 Sum_probs=11.1
Q ss_pred CCeEEecCCCccc
Q psy11469 1 MPKFFLGENPFEC 13 (267)
Q Consensus 1 ~~~l~L~~NP~~C 13 (267)
|++|+|++|++..
T Consensus 4 L~~LdL~~N~i~~ 16 (28)
T smart00368 4 LRELDLSNNKLGD 16 (28)
T ss_pred cCEEECCCCCCCH
Confidence 6899999999854
No 26
>PF04723 GRDA: Glycine reductase complex selenoprotein A; InterPro: IPR006812 Found in clostridia, this protein contains one active site selenocysteine and catalyses the reductive deamination of glycine, which is coupled to the esterification of orthophosphate resulting in the formation of ATP []. A member of this family may also exist in Treponema denticola [].; GO: 0030699 glycine reductase activity, 0050485 oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond, with a disulfide as acceptor, 0055114 oxidation-reduction process, 0030700 glycine reductase complex
Probab=43.97 E-value=1.7e+02 Score=23.59 Aligned_cols=85 Identities=12% Similarity=0.189 Sum_probs=45.3
Q ss_pred EEEEecCCCCCCcccHHHHHHHHHHhcCE-EEEEecCCcccc--cCcHHHHHHHHHHHhhcCCCcEEEEEcCCCCCcccc
Q psy11469 166 KLRVHHRDLNPNLISTADFVTNSIERSEK-VIMVLSRAFIYG--DWSRPEFKSALNGSLMRHRKPLFIIMLPPHSNILVI 242 (267)
Q Consensus 166 ~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~-~I~VlS~~fl~s--~w~~~e~~~a~~~~~~~~~~~lI~v~~~~i~~~~~~ 242 (267)
-+.+.+||-.||. . |.++++.+.- +||.-+.=|+-. .-...|-+.-.....+....-=+.|+++.-..+.
T Consensus 8 viiiGdRDGiPgp-A----ie~c~~~~gaevvfs~TeCFVctaagaMDLEnQ~rvk~~aEk~g~enlvVvlG~aeaE~-- 80 (150)
T PF04723_consen 8 VIIIGDRDGIPGP-A----IEECVKTAGAEVVFSSTECFVCTAAGAMDLENQQRVKDLAEKYGAENLVVVLGAAEAEA-- 80 (150)
T ss_pred EEEEecCCCCCcH-H----HHHHHHhcCceEEEEeeeEEEecccccccHHHHHHHHHHHHhcCCccEEEEecCCChhh--
Confidence 3468999999997 4 4556666554 555555556633 2334444444444444433333344555444332
Q ss_pred CCccHHHHHHHhhhcccCCCCCC
Q psy11469 243 MPMSIYHLSVLLQDNQASGNSIF 265 (267)
Q Consensus 243 ~p~~~~~l~~l~~~~~~~~~~~~ 265 (267)
..+-..-.|.|++.|
T Consensus 81 --------a~laAETVt~GDPTf 95 (150)
T PF04723_consen 81 --------AGLAAETVTNGDPTF 95 (150)
T ss_pred --------hhhhhhhhccCCCcc
Confidence 123344556666665
No 27
>PF10609 ParA: ParA/MinD ATPase like; InterPro: IPR019591 This entry represents ATPases involved in plasmid partitioning []. It also contains cytosolic Fe-S cluster assembling factors, NBP35 and CFD1 which are required for biogenesis and export of both ribosomal subunits probably through assembling the ISCs in RLI1, a protein which performs rRNA processing and ribosome export [, , ].; PDB: 2PH1_A 3KB1_B.
Probab=43.09 E-value=37 Score=24.71 Aligned_cols=45 Identities=13% Similarity=-0.023 Sum_probs=28.6
Q ss_pred CCCCCCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHHHHHHH
Q psy11469 172 RDLNPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPEFKSAL 217 (267)
Q Consensus 172 rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e~~~a~ 217 (267)
-|++||..+..=.+.+.+. ....|+|-+|+-+...-.+....++.
T Consensus 6 iD~PPGTgD~~l~~~~~~~-~~g~ivVTTPq~la~~dv~r~~~~~~ 50 (81)
T PF10609_consen 6 IDLPPGTGDEHLTLMQYLP-IDGAIVVTTPQELALADVRRAIDMFR 50 (81)
T ss_dssp EE--SCSSSHHHHHHHHH---SEEEEEE-CCC--HHHHHHHHHHHH
T ss_pred EeCCCCCCcHHHHHHHhCC-CCeEEEEeCCHHHHHHHHHHHHHHHH
Confidence 3889998777777777776 77889999999887766666666653
No 28
>cd00138 PLDc Phospholipase D. Active site motifs; The PLD superfamily includes enzymes involved in signal transduction, lipid biosynthesis, endonucleases and open reading frames in pathogenic viruses and bacteria. PLD hydrolyzes the terminal phosphodiester bond of phospholipids to phosphatidic acid and a hydrophilic constituent. Phosphatidic acid is a compound that is heavily involved in signal transduction. The common features of the family members are that they can bind to a phosphodiester moiety, and that most of these enzymes are active as bi-lobed monomers or dimers.
Probab=41.24 E-value=88 Score=25.05 Aligned_cols=28 Identities=21% Similarity=0.171 Sum_probs=18.1
Q ss_pred CCcccHHHHHHHHHHhcCEEEEEecCCcc
Q psy11469 176 PNLISTADFVTNSIERSEKVIMVLSRAFI 204 (267)
Q Consensus 176 ~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl 204 (267)
.|. .+.+.+.+.|.+|++.|.+.++.|-
T Consensus 18 ~~~-~~~~~i~~~I~~A~~~I~i~~~~~~ 45 (176)
T cd00138 18 GGR-SDLDALLEAISNAKKSIYIASFYLS 45 (176)
T ss_pred Ccc-hHHHHHHHHHHhhheEEEEEEeEec
Confidence 444 6666777777777777777776443
No 29
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=36.42 E-value=20 Score=19.12 Aligned_cols=12 Identities=17% Similarity=0.271 Sum_probs=8.1
Q ss_pred CCeEEecCCCcc
Q psy11469 1 MPKFFLGENPFE 12 (267)
Q Consensus 1 ~~~l~L~~NP~~ 12 (267)
|++|+|++|++.
T Consensus 4 L~~L~l~~n~i~ 15 (24)
T PF13516_consen 4 LETLDLSNNQIT 15 (24)
T ss_dssp -SEEE-TSSBEH
T ss_pred CCEEEccCCcCC
Confidence 678999999854
No 30
>PRK13793 nicotinamide-nucleotide adenylyltransferase; Provisional
Probab=36.28 E-value=2.7e+02 Score=23.71 Aligned_cols=78 Identities=14% Similarity=0.112 Sum_probs=50.6
Q ss_pred HHHHHHHHHHhcCEEEEEecCCcc----cccCcHHHHHHHHHHHhhc-CCCcEEEEEcCCCCCccccCCccHHHHHHHhh
Q psy11469 181 TADFVTNSIERSEKVIMVLSRAFI----YGDWSRPEFKSALNGSLMR-HRKPLFIIMLPPHSNILVIMPMSIYHLSVLLQ 255 (267)
Q Consensus 181 ~~~~i~~~i~~Sr~~I~VlS~~fl----~s~w~~~e~~~a~~~~~~~-~~~~lI~v~~~~i~~~~~~~p~~~~~l~~l~~ 255 (267)
-...|..|.++++.+|+++-.+-. +++|.-.|=...+...+.+ ...|++.|-++|+..+. .-..+++.+..
T Consensus 20 Hl~~I~~al~~~devII~IGSA~~s~t~~NPFTa~ER~~MI~~aL~e~~~~rv~~ipi~D~~~~~----~Wv~~V~~~v~ 95 (196)
T PRK13793 20 HMQTIEIALQQSRYVILALGSAQMERNIKNPFLAIEREQMILSNFSLDEQKRIRFVHVVDVYNDE----KWVKQVKSLVN 95 (196)
T ss_pred HHHHHHHHHHhCCEEEEEEccCCCCCCCCCCCCHHHHHHHHHHhcchhhcceEEEEecCCccchh----HHHHHHHHhch
Confidence 467889999999999999876543 5778877777777777643 33466665556664333 22345555542
Q ss_pred hcccCCCC
Q psy11469 256 DNQASGNS 263 (267)
Q Consensus 256 ~~~~~~~~ 263 (267)
...+||+
T Consensus 96 -~v~~~n~ 102 (196)
T PRK13793 96 -GVIEPNS 102 (196)
T ss_pred -hhccCCC
Confidence 3446665
No 31
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=35.80 E-value=23 Score=19.18 Aligned_cols=11 Identities=18% Similarity=0.350 Sum_probs=8.4
Q ss_pred CCeEEecCCCc
Q psy11469 1 MPKFFLGENPF 11 (267)
Q Consensus 1 ~~~l~L~~NP~ 11 (267)
|++|+|++|.+
T Consensus 4 L~~L~L~~N~l 14 (26)
T smart00370 4 LRELDLSNNQL 14 (26)
T ss_pred CCEEECCCCcC
Confidence 57888888864
No 32
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=35.80 E-value=23 Score=19.18 Aligned_cols=11 Identities=18% Similarity=0.350 Sum_probs=8.4
Q ss_pred CCeEEecCCCc
Q psy11469 1 MPKFFLGENPF 11 (267)
Q Consensus 1 ~~~l~L~~NP~ 11 (267)
|++|+|++|.+
T Consensus 4 L~~L~L~~N~l 14 (26)
T smart00369 4 LRELDLSNNQL 14 (26)
T ss_pred CCEEECCCCcC
Confidence 57888888864
No 33
>cd00860 ThrRS_anticodon ThrRS Threonyl-anticodon binding domain. ThrRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only.
Probab=32.57 E-value=1e+02 Score=21.58 Aligned_cols=62 Identities=15% Similarity=0.128 Sum_probs=39.3
Q ss_pred CCceeecCC-CCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCccc
Q psy11469 136 CQAYVIYSL-KDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIY 205 (267)
Q Consensus 136 ~DaFIsy~~-~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~ 205 (267)
+|++|...+ .+.+-+. .+...|.+ .|+++-++.+.-.+| ..+..|-..--+.++++.++.+.
T Consensus 2 ~~v~ii~~~~~~~~~a~-~~~~~Lr~--~g~~v~~d~~~~~~~-----~~~~~a~~~g~~~~iiig~~e~~ 64 (91)
T cd00860 2 VQVVVIPVTDEHLDYAK-EVAKKLSD--AGIRVEVDLRNEKLG-----KKIREAQLQKIPYILVVGDKEVE 64 (91)
T ss_pred eEEEEEeeCchHHHHHH-HHHHHHHH--CCCEEEEECCCCCHH-----HHHHHHHHcCCCEEEEECcchhh
Confidence 465555544 4556666 68888877 499998877654444 55566655555566666665543
No 34
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=31.44 E-value=32 Score=21.55 Aligned_cols=12 Identities=25% Similarity=0.534 Sum_probs=9.3
Q ss_pred CCeEEecCCCcc
Q psy11469 1 MPKFFLGENPFE 12 (267)
Q Consensus 1 ~~~l~L~~NP~~ 12 (267)
|++|+|++|++.
T Consensus 26 L~~L~l~~N~i~ 37 (44)
T PF12799_consen 26 LETLNLSNNPIS 37 (44)
T ss_dssp SSEEEETSSCCS
T ss_pred CCEEEecCCCCC
Confidence 577888888865
No 35
>PF09101 Exotox-A_bind: Exotoxin A binding; InterPro: IPR015185 This domain is found in Pseudomonas aeruginosa exotoxin A, and is responsible for binding of the toxin to the alpha-2-macroglobulin receptor, with subsequent internalisation into endosomes. It adopts a thirteen-strand antiparallel beta jelly roll topology, which belongs to the concanavalin A-like lectins/glucanases fold superfamily []. ; PDB: 2Q5T_A 3Q9O_A 1IKP_A 1IKQ_A.
Probab=29.65 E-value=5.6 Score=34.07 Aligned_cols=35 Identities=20% Similarity=0.255 Sum_probs=28.9
Q ss_pred eecCCCCHHHHHHhhhhccCCCCCceEEEEecCCC
Q psy11469 140 VIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRDL 174 (267)
Q Consensus 140 Isy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~ 174 (267)
-||..+..+|+.+||+|.-|+.+..+++.+++-|-
T Consensus 101 ysy~r~~~~~ainwlvpig~~~pa~iki~i~el~~ 135 (262)
T PF09101_consen 101 YSYNRKEGEFAINWLVPIGEDSPASIKISIDELDQ 135 (262)
T ss_dssp EEEE-SSSEEEEEEEEEECTTS-SEEEEEEEEE-T
T ss_pred EEEecccccEEEEEEeEcCCCCCcceEEEhhHhhc
Confidence 38999988999999999999987899999998774
No 36
>PLN02352 phospholipase D epsilon
Probab=28.65 E-value=1.7e+02 Score=30.29 Aligned_cols=55 Identities=22% Similarity=0.422 Sum_probs=41.6
Q ss_pred cHHHHHHHHHHhcCEEEEEecCCcccc--cCcHH-----------HHHHHHHHHhhcCCCcEEEEEcC
Q psy11469 180 STADFVTNSIERSEKVIMVLSRAFIYG--DWSRP-----------EFKSALNGSLMRHRKPLFIIMLP 234 (267)
Q Consensus 180 ~~~~~i~~~i~~Sr~~I~VlS~~fl~s--~w~~~-----------e~~~a~~~~~~~~~~~lI~v~~~ 234 (267)
+|.+.-.++|++|++.|.|=..=|+.| .|... |+..++.+.++++.+-=+.|+++
T Consensus 453 SIq~AYi~AIr~AqhfIYIENQYFiss~~~w~~~~~~~~~N~I~~eIa~kI~~kir~~e~f~V~IViP 520 (758)
T PLN02352 453 SIHEAYVEAIRRAERFIYIENQYFIGGCHLWEKDNHCGCTNLIPIEIALKIASKIRAKERFAVYILIP 520 (758)
T ss_pred HHHHHHHHHHHhhhhEEEEehhhhhccccccccccccchhcchHHHHHHHHHHHHhCCCCCEEEEEEC
Confidence 788888999999999999988888876 36543 78888888888776644444444
No 37
>cd00738 HGTP_anticodon HGTP anticodon binding domain, as found at the C-terminus of histidyl, glycyl, threonyl and prolyl tRNA synthetases, which are classified as a group of class II aminoacyl-tRNA synthetases (aaRS). In aaRSs, the anticodon binding domain is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only. This domain is also found in the accessory subunit of mitochondrial polymerase gamma (Pol gamma b).
Probab=27.64 E-value=1.7e+02 Score=20.52 Aligned_cols=61 Identities=10% Similarity=0.119 Sum_probs=38.7
Q ss_pred CCceeecCC----CCHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCcc
Q psy11469 136 CQAYVIYSL----KDEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFI 204 (267)
Q Consensus 136 ~DaFIsy~~----~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl 204 (267)
++++|.+.+ .....+. .+...|.. .|+++-++.+. . ++-..+..|-..--..++++.++.+
T Consensus 2 ~~v~ii~~~~~~~~~~~~a~-~~~~~Lr~--~g~~v~~~~~~----~-~~~k~~~~a~~~g~~~~iiig~~e~ 66 (94)
T cd00738 2 IDVAIVPLTDPRVEAREYAQ-KLLNALLA--NGIRVLYDDRE----R-KIGKKFREADLRGVPFAVVVGEDEL 66 (94)
T ss_pred eEEEEEECCCCcHHHHHHHH-HHHHHHHH--CCCEEEecCCC----c-CHhHHHHHHHhCCCCEEEEECCChh
Confidence 355555443 3456666 57778876 48998876643 3 5555666665555578888887554
No 38
>PLN02866 phospholipase D
Probab=26.50 E-value=1.2e+02 Score=32.35 Aligned_cols=60 Identities=13% Similarity=0.282 Sum_probs=44.2
Q ss_pred CCcccHHHHHHHHHHhcCEEEEE----ecCCc-cc---ccCcHHHHHHHHHHHhhcCCCcEEEEEcCCCC
Q psy11469 176 PNLISTADFVTNSIERSEKVIMV----LSRAF-IY---GDWSRPEFKSALNGSLMRHRKPLFIIMLPPHS 237 (267)
Q Consensus 176 ~G~~~~~~~i~~~i~~Sr~~I~V----lS~~f-l~---s~w~~~e~~~a~~~~~~~~~~~lI~v~~~~i~ 237 (267)
-|. .+.+++.++|++|++.|.+ |||.+ +. .......+..++.+..++ +-+|-+++++.+.
T Consensus 341 DG~-dyF~AL~eAIe~AKesI~I~~WwlsPEiYL~Rp~~D~~g~RL~~lL~rKAkr-GVkVrVLLyD~vg 408 (1068)
T PLN02866 341 DGH-AAFEAIASAIENAKSEIFITGWWLCPELYLRRPFHDHESSRLDSLLEAKAKQ-GVQIYILLYKEVA 408 (1068)
T ss_pred CHH-HHHHHHHHHHHhcccEEEEEEccCCceEEEEecCCCchHHHHHHHHHHHHHC-CCEEEEEEECccc
Confidence 466 8999999999999999999 88764 43 345667788888775444 3456666677654
No 39
>cd02168 NMNAT_Nudix Nicotinamide/nicotinate mononucleotide adenylyltransferase of bifunctional proteins, also containing a Nudix hydrolase domain. N-terminal NMNAT (Nicotinamide/nicotinate mononucleotide adenylyltransferase) domain of a novel bifunctional enzyme endowed with NMN adenylyltransferase and Nudix hydrolase activities. This domain is highly homologous to the archeal NMN adenyltransferase that catalyzes NAD synthesis from NMN and ATP. NMNAT is an essential enzyme in the biosynthesis of NAD(+) and NADP(+). Nicotinamide-nucleotide adenylyltransferase synthesizes NAD via the salvage pathway, while nicotinate-nucleotide adenylyltransferase synthesizes the immediate precursor of NAD via the de novo pathway. The C-terminal domain of this enzyme shares homology with the archaeal ADP-ribose pyrophosphatase, a member of the 'Nudix' hydrolase family.
Probab=26.12 E-value=3.8e+02 Score=22.24 Aligned_cols=55 Identities=20% Similarity=0.332 Sum_probs=32.3
Q ss_pred HHHHHHHHHHhcCEEEEEecCC-cc---cccCcHHHHHHH-HHHHhhc---CCCcEEEEEcCCC
Q psy11469 181 TADFVTNSIERSEKVIMVLSRA-FI---YGDWSRPEFKSA-LNGSLMR---HRKPLFIIMLPPH 236 (267)
Q Consensus 181 ~~~~i~~~i~~Sr~~I~VlS~~-fl---~s~w~~~e~~~a-~~~~~~~---~~~~lI~v~~~~i 236 (267)
-...+..+.++++++|++++.+ .. +..+. .|-|.+ +..++.+ ...++..+-+++.
T Consensus 15 Hl~~i~~a~~~~~~vii~i~s~~~~~~~~~p~~-~~eR~~mi~~~~~~~~~~~~rv~i~pi~D~ 77 (181)
T cd02168 15 HLAVVLIALEKAKKVIILIGSARTARNIKNPWT-SEEREVMIEAALSDAGADLARVHFRPLRDH 77 (181)
T ss_pred HHHHHHHHHHHCCeEEEEeCCCCCCCCCCCCcC-HHHHHHHHHHHHhccCCCcceEEEEecCCC
Confidence 3567788999999999988443 32 33343 333333 3343444 2346666666665
No 40
>PF00009 GTP_EFTU: Elongation factor Tu GTP binding domain; InterPro: IPR000795 Elongation factors belong to a family of proteins that promote the GTP-dependent binding of aminoacyl tRNA to the A site of ribosomes during protein biosynthesis, and catalyse the translocation of the synthesised protein chain from the A to the P site. The proteins are all relatively similar in the vicinity of their C-termini, and are also highly similar to a range of proteins that includes the nodulation Q protein from Rhizobium meliloti (Sinorhizobium meliloti), bacterial tetracycline resistance proteins [] and the omnipotent suppressor protein 2 from yeast. In both prokaryotes and eukaryotes, there are three distinct types of elongation factors, EF-1alpha (EF-Tu), which binds GTP and an aminoacyl-tRNAand delivers the latter to the A site of ribosomes; EF-1beta (EF-Ts), which interacts with EF-1a/EF-Tu to displace GDP and thus allows the regeneration of GTP-EF-1a; and EF-2 (EF-G), which binds GTP and peptidyl-tRNA and translocates the latter from the A site to the P site. In EF-1-alpha, a specific region has been shown [] to be involved in a conformational change mediated by the hydrolysis of GTP to GDP. This region is conserved in both EF-1alpha/EF-Tu as well as EF-2/EF-G and thus seems typical for GTP-dependent proteins which bind non-initiator tRNAs to the ribosome. The GTP-binding protein synthesis factor family also includes the eukaryotic peptide chain release factor GTP-binding subunits [] and prokaryotic peptide chain release factor 3 (RF-3) []; the prokaryotic GTP-binding protein lepA and its homologue in yeast (GUF1) and Caenorhabditis elegans (ZK1236.1); yeast HBS1 []; rat statin S1 []; and the prokaryotic selenocysteine-specific elongation factor selB [].; GO: 0003924 GTPase activity, 0005525 GTP binding; PDB: 3IZW_C 1DG1_G 2BVN_B 3IZV_C 3MMP_C 1OB2_A 1EFU_A 3FIH_Z 3TR5_A 1TUI_C ....
Probab=25.75 E-value=2e+02 Score=23.50 Aligned_cols=27 Identities=11% Similarity=0.215 Sum_probs=17.7
Q ss_pred CCcccHHHHHHHHHHhcCEEEEEecCC
Q psy11469 176 PNLISTADFVTNSIERSEKVIMVLSRA 202 (267)
Q Consensus 176 ~G~~~~~~~i~~~i~~Sr~~I~VlS~~ 202 (267)
||...+..++..++..++-.|+|++..
T Consensus 78 PG~~~f~~~~~~~~~~~D~ailvVda~ 104 (188)
T PF00009_consen 78 PGHEDFIKEMIRGLRQADIAILVVDAN 104 (188)
T ss_dssp SSSHHHHHHHHHHHTTSSEEEEEEETT
T ss_pred ccccceeecccceecccccceeeeecc
Confidence 554355666667777777777777664
No 41
>cd03415 CbiX_CbiC Archaeal sirohydrochlorin cobalt chelatase (CbiX) single domain. Proteins in this subgroup contain a single CbiX domain N-terminal to a precorrin-8X methylmutase (CbiC) domain. CbiX is a cobaltochelatase, responsible for the chelation of Co2+ into sirohydrochlorin, while CbiC catalyzes the conversion of cobalt-precorrin 8 to cobyrinic acid by methyl rearrangement. Both CbiX and CbiC are involved in vitamin B12 biosynthesis.
Probab=25.37 E-value=2.5e+02 Score=21.89 Aligned_cols=97 Identities=12% Similarity=0.128 Sum_probs=52.3
Q ss_pred eeecCCCCHHHHH--HhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHh-cCEEEEEecCCccccc-CcHHHHH
Q psy11469 139 YVIYSLKDEPFVK--QILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIER-SEKVIMVLSRAFIYGD-WSRPEFK 214 (267)
Q Consensus 139 FIsy~~~D~~~v~--~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~-Sr~~I~VlS~~fl~s~-w~~~e~~ 214 (267)
.|+|.+.|.+|.. ..+...|+++ .++.+....-++... ++.+.+.+.+.+ .+++++| |=|+... -.+.++-
T Consensus 5 lvgHGSR~~~~~~~~~~la~~l~~~-~~~~v~~afle~~~P--~l~~~l~~l~~~G~~~ivVv--PlFL~~G~Hv~~DiP 79 (125)
T cd03415 5 IITHGSRRNTFNEDMEEWAAYLERK-LGVPVYLTYNEYAEP--NWRDLLNELLSEGYGHIIIA--LAFLGRGNHVARDIM 79 (125)
T ss_pred EEecCCCChHHHHHHHHHHHHHHhc-cCCceEEEEeecCCC--CHHHHHHHHHHCCCCEEEEe--hhhccCCcchHHHHH
Confidence 4677788865532 2577777654 455544443443332 567777776664 4555544 9888764 3445555
Q ss_pred HHHHHH-------hhcCCCcEEEEEcCCCCCcc
Q psy11469 215 SALNGS-------LMRHRKPLFIIMLPPHSNIL 240 (267)
Q Consensus 215 ~a~~~~-------~~~~~~~lI~v~~~~i~~~~ 240 (267)
.++... .+....++=.++.+++.++.
T Consensus 80 ~~l~~~~~~~~~~~~~~~~~~~i~~~~pLG~~p 112 (125)
T cd03415 80 GELGVSRFYKWVMSKYGGKEILVYVTEPLADSP 112 (125)
T ss_pred HHHHhhcccchhhhccCCCCceEEEeCCCCCCH
Confidence 555431 11111233345666776654
No 42
>KOG2869|consensus
Probab=23.50 E-value=1.4e+02 Score=27.82 Aligned_cols=42 Identities=21% Similarity=0.264 Sum_probs=33.6
Q ss_pred cHHHHHHHHHHhc-----CEEEEEecCCcccccCcHHHHHHHHHHHh
Q psy11469 180 STADFVTNSIERS-----EKVIMVLSRAFIYGDWSRPEFKSALNGSL 221 (267)
Q Consensus 180 ~~~~~i~~~i~~S-----r~~I~VlS~~fl~s~w~~~e~~~a~~~~~ 221 (267)
-+.++|.+|+.+- =|+++|-||.|.....+.+-|+.|-...+
T Consensus 184 kfye~V~qA~~k~v~fd~vk~~vvASpgF~~~~~~d~~~q~A~~~~~ 230 (379)
T KOG2869|consen 184 KFYENVVQAILKHVNFDVVKCVVVASPGFVKDQFMDYLFQQAVKLDL 230 (379)
T ss_pred HHHHHHHHHHHHhcCcceEEEEEEcCCchhHHHHHHHHHHHHHHhch
Confidence 4667888888652 36899999999999999999999976443
No 43
>PRK10569 NAD(P)H-dependent FMN reductase; Provisional
Probab=22.84 E-value=4.5e+02 Score=21.91 Aligned_cols=98 Identities=11% Similarity=0.114 Sum_probs=52.6
Q ss_pred HhhhhccCCCCCceEE-EEecCCCCCCc-------ccHHHHHHHHHHhcCEEEEEecCCcccccCcHHHHHHHHHHHhh-
Q psy11469 152 QILLPGLAFKDPAVKL-RVHHRDLNPNL-------ISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPEFKSALNGSLM- 222 (267)
Q Consensus 152 ~~L~~~Le~~~~g~~v-~~~~rD~~~G~-------~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e~~~a~~~~~~- 222 (267)
+.....|++ .|..+ .++-+|++++. ..-.+.+.+.|++++. |++.||.|-.|- .--++.++.....
T Consensus 21 ~~~~~~l~~--~g~ev~~idL~~l~~~~~~~~~~~~~~~~~~~~~i~~AD~-iIi~tP~Y~~s~--pg~LKn~iD~l~~~ 95 (191)
T PRK10569 21 EYAREWLNG--LGVEVYHWNLQNFAPEDLLYARFDSPALKTFTEQLAQADG-LIVATPVYKASF--SGALKTLLDLLPER 95 (191)
T ss_pred HHHHHHHHh--CCCEEEEEEccCCChHHHHhccCCCHHHHHHHHHHHHCCE-EEEECCccCCCC--CHHHHHHHHhCChh
Confidence 345555654 25544 34445555421 0355677888889885 566899987653 2334444433321
Q ss_pred -cCCCcEEEEEcCCCCCccccCCccH-HHHHHHhhhcc
Q psy11469 223 -RHRKPLFIIMLPPHSNILVIMPMSI-YHLSVLLQDNQ 258 (267)
Q Consensus 223 -~~~~~lI~v~~~~i~~~~~~~p~~~-~~l~~l~~~~~ 258 (267)
-..+.+.+|-...-+... ... ++||.++..-.
T Consensus 96 ~l~~K~v~iiat~G~~~~~----~~~~~~lr~~l~~l~ 129 (191)
T PRK10569 96 ALEHKVVLPLATGGSVAHM----LAVDYALKPVLSALK 129 (191)
T ss_pred hhCCCEEEEEEecCCchhH----HHHHHHHHHHHHHcC
Confidence 134456666655333332 234 67776665443
No 44
>PHA02820 phospholipase-D-like protein; Provisional
Probab=21.35 E-value=3.5e+02 Score=25.82 Aligned_cols=41 Identities=17% Similarity=0.170 Sum_probs=31.0
Q ss_pred cHHHHHHHHHHhcCEEEEEecCCcccccC-------cHHHHHHHHHHH
Q psy11469 180 STADFVTNSIERSEKVIMVLSRAFIYGDW-------SRPEFKSALNGS 220 (267)
Q Consensus 180 ~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w-------~~~e~~~a~~~~ 220 (267)
...+.+.++|.+|++.|-+-+|.|+=+.. ...++..|+.++
T Consensus 218 ~~~~~~l~~I~~Ak~~I~I~tpyfvP~~~~~~~~~~yw~~i~~AL~~A 265 (424)
T PHA02820 218 NDLTALLSCIRNASKFVYVSVMNFIPIIYSKAGKILFWPYIEDELRRA 265 (424)
T ss_pred chHHHHHHHHHHHhhEEEEEEccccceeeccCCcccchHHHHHHHHHH
Confidence 34688999999999999999999997711 115677777653
No 45
>PRK11263 cardiolipin synthase 2; Provisional
Probab=21.17 E-value=1.7e+02 Score=27.76 Aligned_cols=46 Identities=11% Similarity=0.051 Sum_probs=30.4
Q ss_pred CCCcccHHHHHHHHHHhcCEEEEEecCCcccccCcHHHHHHHHHHHhh
Q psy11469 175 NPNLISTADFVTNSIERSEKVIMVLSRAFIYGDWSRPEFKSALNGSLM 222 (267)
Q Consensus 175 ~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s~w~~~e~~~a~~~~~~ 222 (267)
.-|+ ++.+.+.++|+++++.|.+.+.-+..+.. ..++..|+.+.-+
T Consensus 14 ~~G~-e~~~~l~~~I~~Ak~~I~i~~yi~~~d~~-g~~l~~aL~~aa~ 59 (411)
T PRK11263 14 ENGE-QYYPRVFEAIAAAQEEILLETFILFEDKV-GKQLHAALLAAAQ 59 (411)
T ss_pred eCHH-HHHHHHHHHHHHhCCEEEEEEEEEecCch-HHHHHHHHHHHHH
Confidence 4566 78888888888888888887765544432 3455555554433
No 46
>cd03111 CpaE_like This protein family consists of proteins similar to the cpaE protein of the Caulobacter pilus assembly and the orf4 protein of Actinobacillus pilus formation gene cluster. The function of these proteins are unkown. The Caulobacter pilus assembly contains 7 genes: pilA, cpaA, cpaB, cpaC, cpaD, cpaE and cpaF. These genes are clustered together on chromosome.
Probab=21.13 E-value=1.8e+02 Score=21.54 Aligned_cols=31 Identities=16% Similarity=0.317 Sum_probs=21.0
Q ss_pred CCCCCcccHHHHHHHHHHhcCEEEEEecCCcccc
Q psy11469 173 DLNPNLISTADFVTNSIERSEKVIMVLSRAFIYG 206 (267)
Q Consensus 173 D~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~s 206 (267)
|..||. .. ...+++..|+.+|+|+.++...-
T Consensus 49 Dtpp~~-~~--~~~~~l~~aD~vlvvv~~~~~s~ 79 (106)
T cd03111 49 DLGRSL-DE--VSLAALDQADRVFLVTQQDLPSI 79 (106)
T ss_pred eCCCCc-CH--HHHHHHHHcCeEEEEecCChHHH
Confidence 444555 33 23568889999999998887543
No 47
>cd00858 GlyRS_anticodon GlyRS Glycyl-anticodon binding domain. GlyRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only.
Probab=20.81 E-value=3.7e+02 Score=20.36 Aligned_cols=61 Identities=8% Similarity=-0.070 Sum_probs=40.5
Q ss_pred CCceeecCC--C-CHHHHHHhhhhccCCCCCceEEEEecCCCCCCcccHHHHHHHHHHhcCEEEEEecCCccc
Q psy11469 136 CQAYVIYSL--K-DEPFVKQILLPGLAFKDPAVKLRVHHRDLNPNLISTADFVTNSIERSEKVIMVLSRAFIY 205 (267)
Q Consensus 136 ~DaFIsy~~--~-D~~~v~~~L~~~Le~~~~g~~v~~~~rD~~~G~~~~~~~i~~~i~~Sr~~I~VlS~~fl~ 205 (267)
+|+||...+ + ....+. .+...|.+ .|+++-++.+ - ++-..+..|-..--+.++++-++-+.
T Consensus 27 ~~v~Ii~~~~~~~~~~~a~-~la~~LR~--~gi~v~~d~~-~-----sl~kqlk~A~k~g~~~~iiiG~~e~~ 90 (121)
T cd00858 27 IKVAVLPLVKRDELVEIAK-EISEELRE--LGFSVKYDDS-G-----SIGRRYARQDEIGTPFCVTVDFDTLE 90 (121)
T ss_pred cEEEEEecCCcHHHHHHHH-HHHHHHHH--CCCEEEEeCC-C-----CHHHHHHHhHhcCCCEEEEECcCchh
Confidence 588888766 2 234565 67888876 5999988765 3 44456666666555677777766554
No 48
>COG4916 Uncharacterized protein containing a TIR (Toll-Interleukin 1-resistance) domain [Function unknown]
Probab=20.56 E-value=1.3e+02 Score=27.03 Aligned_cols=97 Identities=11% Similarity=0.140 Sum_probs=67.3
Q ss_pred CCCceeecCCCCHHHHHHhhhhccCCCCCceEEEEecCCC--CCCcccHHHHHHHHH-HhcCEEEEEecCCcccccCcHH
Q psy11469 135 PCQAYVIYSLKDEPFVKQILLPGLAFKDPAVKLRVHHRDL--NPNLISTADFVTNSI-ERSEKVIMVLSRAFIYGDWSRP 211 (267)
Q Consensus 135 ~~DaFIsy~~~D~~~v~~~L~~~Le~~~~g~~v~~~~rD~--~~G~~~~~~~i~~~i-~~Sr~~I~VlS~~fl~s~w~~~ 211 (267)
.+..-+||.+.|.+.|.+ ....+.+ +|..++++--|- .-|. ++.+-+.+-- +..-.++..+|.+|-.-.|.+.
T Consensus 6 ~~~~a~~f~~~d~~~~~~-~~n~~~~--~~v~~~y~~~~~a~~~~~-~~~~~~~e~~q~~~~~~~~f~~~~~~r~~~~~~ 81 (329)
T COG4916 6 QFEIALSFAGEDREYVDR-VANLLRE--AGVTVFYDIFEEANLWGK-NLYDYLSEIYQDKALFTIMFISEHYSRKMWTNH 81 (329)
T ss_pred heeeeeeecCchHHHHHH-HHHHHHh--hccEEEEeehhhhhhhhh-HHHHHHHHHHhhhhHHHhhhhhccccCcCCCcH
Confidence 346678999999999974 5555555 477777665442 2444 5554443322 2355577888999999999999
Q ss_pred HHHHHHHHHhhcCCCcEEEEEcCC
Q psy11469 212 EFKSALNGSLMRHRKPLFIIMLPP 235 (267)
Q Consensus 212 e~~~a~~~~~~~~~~~lI~v~~~~ 235 (267)
|.+..+.+...+....++|-.++.
T Consensus 82 ~~~~~~a~~~~~~~~~~~~~~~~~ 105 (329)
T COG4916 82 ERQAMQARAFQEHQEYILPARFDE 105 (329)
T ss_pred HHHHHHHHHhhhccEEehhhhhcc
Confidence 999998888877766666666553
No 49
>PF09419 PGP_phosphatase: Mitochondrial PGP phosphatase; InterPro: IPR010021 This group of hypothetical proteins is a part of the IIIA subfamily of the haloacid dehalogenase (HAD) superfamily of hydrolases. All characterised members of this subfamily and most characterised members of the HAD superfamily are phosphatases. HAD superfamily phosphatases contain active site residues in several conserved catalytic motifs [], all of which are found conserved here. This family consists of sequences from fungi, plants, cyanobacteria, Gram-positive bacteria and Deinococcus. There is presently no characterisation of any sequence in this family.
Probab=20.38 E-value=3.8e+02 Score=22.17 Aligned_cols=47 Identities=13% Similarity=0.091 Sum_probs=33.3
Q ss_pred cCCCCCceEEEEecCCC---CCCcccHHHHHHHHHHhcCE-----EEEEecCCcccc
Q psy11469 158 LAFKDPAVKLRVHHRDL---NPNLISTADFVTNSIERSEK-----VIMVLSRAFIYG 206 (267)
Q Consensus 158 Le~~~~g~~v~~~~rD~---~~G~~~~~~~i~~~i~~Sr~-----~I~VlS~~fl~s 206 (267)
|.+ .|++..+-+.|= .|+...+.+.+.+.+++.++ -|+|+|.+.=.+
T Consensus 36 Lk~--~Gik~li~DkDNTL~~~~~~~i~~~~~~~~~~l~~~~~~~~v~IvSNsaGs~ 90 (168)
T PF09419_consen 36 LKK--KGIKALIFDKDNTLTPPYEDEIPPEYAEWLNELKKQFGKDRVLIVSNSAGSS 90 (168)
T ss_pred hhh--cCceEEEEcCCCCCCCCCcCcCCHHHHHHHHHHHHHCCCCeEEEEECCCCcc
Confidence 555 699998888885 35654566777777777664 389999986333
No 50
>cd01884 EF_Tu EF-Tu subfamily. This subfamily includes orthologs of translation elongation factor EF-Tu in bacteria, mitochondria, and chloroplasts. It is one of several GTP-binding translation factors found in the larger family of GTP-binding elongation factors. The eukaryotic counterpart, eukaryotic translation elongation factor 1 (eEF-1 alpha), is excluded from this family. EF-Tu is one of the most abundant proteins in bacteria, as well as, one of the most highly conserved, and in a number of species the gene is duplicated with identical function. When bound to GTP, EF-Tu can form a complex with any (correctly) aminoacylated tRNA except those for initiation and for selenocysteine, in which case EF-Tu is replaced by other factors. Transfer RNA is carried to the ribosome in these complexes for protein translation.
Probab=20.32 E-value=3.8e+02 Score=22.33 Aligned_cols=27 Identities=15% Similarity=0.219 Sum_probs=18.4
Q ss_pred CCcccHHHHHHHHHHhcCEEEEEecCC
Q psy11469 176 PNLISTADFVTNSIERSEKVIMVLSRA 202 (267)
Q Consensus 176 ~G~~~~~~~i~~~i~~Sr~~I~VlS~~ 202 (267)
||...+..++..++..++.+|+|++..
T Consensus 73 PG~~~~~~~~~~~~~~~D~~ilVvda~ 99 (195)
T cd01884 73 PGHADYIKNMITGAAQMDGAILVVSAT 99 (195)
T ss_pred cCHHHHHHHHHHHhhhCCEEEEEEECC
Confidence 554255666777777888888887754
Done!